Literature DB >> 20357805

Mcl1 becomes ubiquitin-ous: new opportunities to antagonize a pro-survival protein.

Michael D Hogarty1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20357805     DOI: 10.1038/cr.2010.37

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  7 in total

1.  Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I).

Authors:  Zhenghong Peng; David S Maxwell; Duoli Sun; Basvoju A Bhanu Prasad; Paul T Schuber; Ashutosh Pal; Yunming Ying; Dongmei Han; Liwei Gao; Shimei Wang; Alexander Levitzki; Vaibhav Kapuria; Moshe Talpaz; Matthew Young; Hollis D Showalter; Nicholas J Donato; William G Bornmann
Journal:  Bioorg Med Chem       Date:  2014-01-03       Impact factor: 3.641

2.  Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastoma.

Authors:  Yvan H Chanthery; W Clay Gustafson; Melissa Itsara; Anders Persson; Christopher S Hackett; Matt Grimmer; Elise Charron; Slava Yakovenko; Grace Kim; Katherine K Matthay; William A Weiss
Journal:  Sci Transl Med       Date:  2012-01-04       Impact factor: 17.956

3.  Mcl-1 Phosphorylation defines ABT-737 resistance that can be overcome by increased NOXA expression in leukemic B cells.

Authors:  Suparna Mazumder; Gaurav S Choudhary; Sayer Al-Harbi; Alexandru Almasan
Journal:  Cancer Res       Date:  2012-04-23       Impact factor: 12.701

4.  Miniature short hairpin RNA screens to characterize antiproliferative drugs.

Authors:  Saranya Kittanakom; Anthony Arnoldo; Kevin R Brown; Iain Wallace; Tada Kunavisarut; Dax Torti; Lawrence E Heisler; Anuradha Surendra; Jason Moffat; Guri Giaever; Corey Nislow
Journal:  G3 (Bethesda)       Date:  2013-08-07       Impact factor: 3.154

5.  The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition.

Authors:  Chander Peddaboina; Daniel Jupiter; Steven Fletcher; Jeremy L Yap; Arun Rai; Richard P Tobin; Weihua Jiang; Philip Rascoe; M Karen Newell Rogers; W Roy Smythe; Xiaobo Cao
Journal:  BMC Cancer       Date:  2012-11-21       Impact factor: 4.430

6.  Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysis.

Authors:  Terence T Sio; Aaron S Mansfield; Travis E Grotz; Rondell P Graham; Julian R Molina; Florencia G Que; Robert C Miller
Journal:  J Hum Genet       Date:  2013-12-26       Impact factor: 3.172

7.  USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment.

Authors:  Rachel Isaksson Vogel; Tanya Pulver; Wiebke Heilmann; Ashley Mooneyham; Sally Mullany; Xianda Zhao; Maryam Shahi; James Richter; Molly Klein; Liqiang Chen; Rui Ding; Gottfried Konecny; Stefan Kommoss; Boris Winterhoff; Rahel Ghebre; Martina Bazzaro
Journal:  Oncotarget       Date:  2016-05-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.